Skip to main content
. Author manuscript; available in PMC: 2016 May 20.
Published in final edited form as: JAMA Dermatol. 2015 May;151(5):539–543. doi: 10.1001/jamadermatol.2014.4409

Table 1.

Anti-type VII collagen IgG levels in sera of BSLE patient 3 months prior, 3 weeks after, and 12 months after disease onset, EBA, normal, DLE, and SLE patients.

Sample Anti-type VII collagen IgG (U/mL)
BSLE patient 3 months before disease onset 9.23
BSLE patient 3 weeks after disease onset 71.74
BSLE patient 12 months after disease onset 2.30
EBA patients (N=2), mean±SD 141.46±67.01
Normal controls (N=14)*, mean±SD 0.11±0.40
DLE patients (N=13)*, mean±SD 0.36±0.93
SLE patients (N=13)*, mean±SD 0.23±0.37
*

Compared with EBA patients, normal, DLE, and SLE patients had significantly lower anti-type VII collagen IgG (p<0.01). Sera for age- and gender-matched normal controls, DLE patients, and SLE patients were obtained from the UTSW Cutaneous Lupus Registry. None of the normal, DLE, and SLE samples was positive.